Cargando…

Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients

Detalles Bibliográficos
Autores principales: Hayashi, Takuma, Konishi, Ikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717053/
https://www.ncbi.nlm.nih.gov/pubmed/34969997
http://dx.doi.org/10.1038/s41416-021-01685-3
_version_ 1784624454008045568
author Hayashi, Takuma
Konishi, Ikuo
author_facet Hayashi, Takuma
Konishi, Ikuo
author_sort Hayashi, Takuma
collection PubMed
description
format Online
Article
Text
id pubmed-8717053
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87170532021-12-30 Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients Hayashi, Takuma Konishi, Ikuo Br J Cancer Comment Nature Publishing Group UK 2021-12-30 2022-03-09 /pmc/articles/PMC8717053/ /pubmed/34969997 http://dx.doi.org/10.1038/s41416-021-01685-3 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021
spellingShingle Comment
Hayashi, Takuma
Konishi, Ikuo
Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients
title Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients
title_full Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients
title_fullStr Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients
title_full_unstemmed Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients
title_short Cancer therapy with decreased SARS-CoV-2 infection rates in cancer patients
title_sort cancer therapy with decreased sars-cov-2 infection rates in cancer patients
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717053/
https://www.ncbi.nlm.nih.gov/pubmed/34969997
http://dx.doi.org/10.1038/s41416-021-01685-3
work_keys_str_mv AT hayashitakuma cancertherapywithdecreasedsarscov2infectionratesincancerpatients
AT konishiikuo cancertherapywithdecreasedsarscov2infectionratesincancerpatients